Stocks and Investing
Stocks and Investing
Fri, May 10, 2024
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
[ Fri, May 10th 2024
] - WOPRAI
Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $10 on, May 10th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $7.5 to $10 on, May 10th, 2024.
Raghuram, nor any peers, have made any analyst calls on ADMA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources